1. Home
  2. CTNM vs BSET Comparison

CTNM vs BSET Comparison

Compare CTNM & BSET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTNM
  • BSET
  • Stock Information
  • Founded
  • CTNM 2009
  • BSET 1902
  • Country
  • CTNM United States
  • BSET United States
  • Employees
  • CTNM N/A
  • BSET N/A
  • Industry
  • CTNM
  • BSET Home Furnishings
  • Sector
  • CTNM
  • BSET Consumer Discretionary
  • Exchange
  • CTNM Nasdaq
  • BSET Nasdaq
  • Market Cap
  • CTNM 142.3M
  • BSET 149.6M
  • IPO Year
  • CTNM 2024
  • BSET 1987
  • Fundamental
  • Price
  • CTNM $5.77
  • BSET $17.43
  • Analyst Decision
  • CTNM Strong Buy
  • BSET
  • Analyst Count
  • CTNM 4
  • BSET 0
  • Target Price
  • CTNM $22.50
  • BSET N/A
  • AVG Volume (30 Days)
  • CTNM 366.4K
  • BSET 105.1K
  • Earning Date
  • CTNM 08-12-2025
  • BSET 07-09-2025
  • Dividend Yield
  • CTNM N/A
  • BSET 4.59%
  • EPS Growth
  • CTNM N/A
  • BSET N/A
  • EPS
  • CTNM N/A
  • BSET 0.28
  • Revenue
  • CTNM N/A
  • BSET $326,469,000.00
  • Revenue This Year
  • CTNM N/A
  • BSET $2.22
  • Revenue Next Year
  • CTNM N/A
  • BSET $3.27
  • P/E Ratio
  • CTNM N/A
  • BSET $62.04
  • Revenue Growth
  • CTNM N/A
  • BSET N/A
  • 52 Week Low
  • CTNM $3.35
  • BSET $12.11
  • 52 Week High
  • CTNM $21.58
  • BSET $19.75
  • Technical
  • Relative Strength Index (RSI)
  • CTNM N/A
  • BSET 50.16
  • Support Level
  • CTNM N/A
  • BSET $17.84
  • Resistance Level
  • CTNM N/A
  • BSET $19.39
  • Average True Range (ATR)
  • CTNM 0.00
  • BSET 1.00
  • MACD
  • CTNM 0.00
  • BSET -0.02
  • Stochastic Oscillator
  • CTNM 0.00
  • BSET 42.29

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

About BSET Bassett Furniture Industries Incorporated

Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.

Share on Social Networks: